Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)
NCT03500562
·
clinicaltrials.gov ↗
TERMINATED
Status
3
Enrollment
INDUSTRY
Sponsor class
Stopped
Insufficient Enrollment
Conditions
Chronic Hepatitis C
Sponsor
Bristol-Myers Squibb